Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
FDA Approval (2)
284 Articles Available
2
12
Can't find what you're looking for? Try our
advanced search
.
FDA Approval
Perrigo and Catalent Announce FDA Approval of Perrigo's AB-Rated Generic Version of ProAir® HFA
PR-M02-20-NI-041
FDA
Olympus Announces FDA Clearance of the TJF-Q190V Duodenoscope
PR-M02-20-NI-008
FDA Approval
FDA Approves Aimmune’s PALFORZIA™ as First Treatment for Peanut Allergy
PR-M01-20-NI-049
Drug Development
LYNPARZA® (olaparib) Approved by FDA as First-Line Maintenance Treatment of Germline BRCA-Mutated Metastatic Pancreatic Cancer
PR-M01-20-NI-003
Insomnia
New Insomnia Treatment Approved by the FDA for Adults
PR-M01-20-NI-002
FDA Approval
Allergan Receives FDA Approval for Migraine Treatment
PR-M01-20-NI-001
Ebola Vaccine
FDA Approves First Vaccine for the Prevention of Ebola Virus Disease
PR-M12-19-NI-035
FDA Approval
FDA Approves First Treatment for Inherited Rare Disease
PR-M12-19-NI-001
FDA Approval
Medtronic Drug-Coated Balloon Receives U.S. FDA Approval to Treat Arteriovenous Fistula Lesions
PR-M11-19-NI-033
FDA Approval
FETROJA Approved for Complicated Urinary Tract Infections
PR-M11-19-NI-021
HIV-1
FDA Authorizes Marketing of First Next-Generation Sequencing Test for Detecting HIV-1 Drug Resistance Mutations
PR-M11-19-NI-008
FDA Approval
GSK Announces U.S. Food and Drug Administration Approval of Additional Indication for Zejula (niraparib) for Late-line Treatment for Women with Recurrent Ovarian Cancer
PR-M10-19-NI-035
FDA Approval
Janssen Announces U.S. FDA Approval of STELARA® (ustekinumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis
PR-M10-19-NI-032
FDA Approval
FDA Approves New Treatment for Patients with Migraine
PR-M10-19-NI-023
HIV Prevention
FDA Approves Second Drug to Prevent HIV Infection as Part of Ongoing Efforts to End the HIV Epidemic
PR-M10-19-NI-008
Wearables
First-ever: FDA Clears Biobeat's Wearable Watch and Patch for Non-invasive Cuffless Monitoring of Blood Pressure
PR-M08-19-NI-091
FDA Approval
FDA Approves New Add-on Drug to Treat Off Episodes in Adults with Parkinson’s disease
PR-M08-19-NI-090
FDA Approval
AbbVie Receives FDA Approval of RINVOQ™ (upadacitinib), an Oral JAK Inhibitor For The Treatment of Moderate to Severe Rheumatoid Arthritis
PR-M08-19-NI-073
FDA Approval
FDA Approves New Antibiotic to Treat Community-Acquired Bacterial Pneumonia
PR-M08-19-NI-061
Pediatric
FDA Approves First of its Kind Device to Treat Pediatric Patients with Progressive Idiopathic Scoliosis
PR-M08-19-NI-054
FDA Approval
FDA Approves New Device to Improve Symptoms in Patients with Advanced Heart Failure
PR-M08-19-NI-055
FDA Approval
FDA Approves New Drug for Treatment-Resistant Forms of Tuberculosis that Affects the Lungs
PR-M08-19-NI-051
FDA Approval
Aptar’s Nasal Unidose Device Approved by US FDA for First Needle-Free Rescue Treatment for Severe Hypoglycemia
PR-M08-19-NI-025
FDA Approval
U.S. FDA Approved New Antibacterial for Urinary Tract and Abdominal Infections
PAO-M08-19-NI-015
«
2
12
»
.svg)